P2RY12 and atrial fibrillation: The major findings of this survey reported that the majority of the cardiologists used triple therapy, and predominantly used NOAC + dual antiplatelets (aspirin and P2Y12 inhibitor) followed by NOAC + single antiplatelet for managing patients with AF and ACS or those undergoing PCI.